QIAGEN Applauds United Nations Bold Plan for Tuberculosis Prevention and Treatment



[ad_1]

QIAGEN N.V. (NYSE: QGEN, Frankfurt's Premier Standard: QIA) applauded today
a commitment from world leaders to attend the first edition
United Nations Tuberculosis (TB) to raise $ 13 billion a year
2022 to implement TB prevention and care, the deadliest in the world
infectious disease. Heads of State meeting at the United Nations
The General Assembly is committed to ensuring that 40 million people
diagnosed with tuberculosis receive the care they need by the end of
2022 and agreed to provide preventive tests and treatment at 30
millions of people.

Prevention is critical to successful TB control because TB
often infects the body, then remains inactive and undetected until – if
untreated – it can surface as an active and contagious disease threatening
the lungs and sometimes other organs. About a third of
the world's population has a latent TB infection, and up to 10
the percentage of infected people will progress to active TB if they are not treated.
Screening at-risk population groups and treatment of infected persons
can prevent latent TB from progressing to an active disease. QIAGEN
QuantiFERON-TB Gold Plus (QFT-Plus), the most accurate test available
for latent tuberculosis infection, is now implemented around the world
tuberculosis control programs.

"We are delighted to see this bold commitment from world leaders
the urgent fight against tuberculosis – and the unprecedented
recognition and funding of TB prevention. This demonstration of
Political will is essential if we want to eradicate the world's deadliest.
infectious disease, "said Dr. Masae Kawamura, MD, Senior Director, TB
Medical and Scientific Affairs, at QIAGEN, who attended the meeting of the UN
on tuberculosis. "QIAGEN continues to be a committed partner with the
World Health Organization, Public Health Agencies and Private Sector
organizations around the world to provide the most accurate,
cost-effective screening available for latent TB. As this new commitment
takes control, we expect that screening with QuantiFERON-TB Gold Plus will play a role
major role in disease prevention and saving lives. "

Please find the full press release here

[ad_2]
Source link